The influence of virus structure on antibody responses and virus serotype formation.
about
Few and far between: how HIV may be evading antibody avidityOptions for control of foot-and-mouth disease: knowledge, capability and policyProtective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particlesGeneral and specific immunosuppression caused by antiviral T-cell responses.Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune systemT-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles.Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretionsRequirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery miceWhy HIV virions have low numbers of envelope spikes: implications for vaccine development.CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans.Exploiting viral properties for the rational design of modern vaccines.Hepatitis B vaccine -- do we need boosters?Therapeutic vaccination to block receptor-ligand interactions.Rabies virus nucleoprotein as a carrier for foreign antigens.Effects of adjuvants on IgG subclasses elicited by virus-like particles.Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation usedConjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies.T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particlesRegulation of innate and acquired immunity in African trypanosomiasis.Protective T cell-independent antiviral antibody responses are dependent on complement.Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine DesignMechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody responsePlant-derived virus-like particles as vaccinesInfluence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccinePresenting native-like trimeric HIV-1 antigens with self-assembling nanoparticlesGenetic manipulation of African trypanosomes as a tool to dissect the immunobiology of infection.Capsid antibodies to different adeno-associated virus serotypes bind common regions.The coming of age of virus-like particle vaccines.Recent developments with B-cell epitope identification for predictive studies.Division of labor during primary humoral immunity.Harnessing Nanoparticles for Immunomodulation and VaccinesUnderstanding and learning from the success of prophylactic human papillomavirus vaccines.Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.Human B cells and macrophages cooperate in T-cell-independent type 2 response.Tumour virus vaccines: hepatitis B virus and human papillomavirus.
P2860
Q21090507-5839159F-1D80-4D49-AB85-811DD36FCB9CQ24628306-D3EB84FE-A943-4DE8-AF40-1F56C8893890Q30390753-261F564E-472B-4E6A-BED8-730EF11A1DF2Q33683440-8D1BA4B8-3AAF-4D14-951D-7549DC35A67BQ33768852-DF9F60A6-0BDB-4184-BD8E-C6556AC19528Q33783572-9580CD67-F22B-4F9A-8A47-841D0EC283D3Q33784891-F023696E-3553-4F93-B8DC-00090529DAB9Q33785520-4857CE47-B86C-40FF-BC81-D2793EAFE734Q34016070-CC90A9F6-7F4F-480F-B72B-0AAB756621CCQ34651496-E2CB1EC3-60CE-4018-8252-B85A63200CA4Q34746490-2B86EBEB-412B-42CE-A0EC-FEBBF29E3451Q35056955-DD62C170-979B-4F3F-A325-6BC47A186E98Q35144038-22B0D802-0928-412A-AED3-BBF09378A359Q35320069-D84FA233-49D0-40F4-971B-1A9B75736198Q35848642-32DE0AE2-9431-43CA-A7BC-C28A0DD2BAC4Q35891225-EB1EBBC7-D9A5-4A6E-941A-101E96E82289Q35927866-7BB72EFA-E203-462F-AF08-8283E0950AB9Q36045879-C3475649-7A1A-4B67-91ED-A78C5FF15710Q36167475-6FF02703-63F8-44AB-A1FD-4FD535C3101EQ36262265-E0935998-CD7F-4C88-94D5-F16090EDEEDDQ36265002-11A65987-F2DA-46B7-982A-23233E05BDCBQ36375462-C4FE9740-8B12-4C1F-A590-7CAE489FF863Q36380593-EF12DE75-B0AD-4F82-AA58-E9D3E770D817Q36407253-AF2022FB-D769-43E6-B9EC-1BB6B078D6C2Q36447540-1EED6D30-38F3-4920-9D0E-2CBB617174F6Q36540127-44545B10-69B8-4616-8E3E-8DFE4F60FDE6Q36673310-A0A0A083-73AD-40C6-9A4B-591A22BF7888Q36888029-3206E19F-6764-4B0C-A5D6-97BE3E06E168Q36970255-3F12AE66-01BF-4814-9A90-1BBD697D5722Q37060947-2E519948-88BF-42AC-AB92-DC8DCC8F37F4Q37061537-44E5B68F-7E3F-4DDF-A989-2C7DFD8FA79DQ37123344-82FADC4B-1B7A-44F8-A627-DF2F21322B1EQ37309265-D060CD60-BB90-4C8E-9C13-82464BFC039CQ37311033-DFBFA868-EB47-4CB5-9661-1C24A096D275Q37719463-6A4F6675-A9B7-49C9-869B-F46AC8CC345BQ37727724-7821E827-DD6E-4A29-9C96-94D4F488BE44Q38041983-ABB5AAE5-5C57-43A7-9B5B-54D507EF89ACQ38156856-175ACB6C-1249-41B9-88C2-B2F8C17B1EBFQ40025312-276C4855-E3B5-4CB2-B5C0-CF2904111342Q40046649-B3E11596-5806-4CD5-98A0-70869A261BE9
P2860
The influence of virus structure on antibody responses and virus serotype formation.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The influence of virus structure on antibody responses and virus serotype formation.
@en
type
label
The influence of virus structure on antibody responses and virus serotype formation.
@en
prefLabel
The influence of virus structure on antibody responses and virus serotype formation.
@en
P1433
P1476
The influence of virus structure on antibody responses and virus serotype formation.
@en
P2093
Bachmann MF
Zinkernagel RM
P304
P356
10.1016/S0167-5699(96)10066-9
P577
1996-12-01T00:00:00Z